Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SPFPLARL PHARMABABA : revenue, balance sheet and financial ratios

SPFPLARL PHARMABABA is a French company founded 8 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in GENSAC (33890), this company of category PME shows in 2022 a net income negative of -14 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SPFPLARL PHARMABABA (SIREN 830358263)
Indicator 2022 2021 2020 2019 2018 2017
Revenue N/C N/C N/C N/C N/C N/C
Net income -14 158 € 127 105 € 150 862 € 125 324 € 623 014 € -2 019 €
EBITDA -3 499 € -3 766 € -3 907 € -3 954 € -3 407 € -1 920 €
Net margin N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2022, SPFPLARL PHARMABABA records a net loss of 14 k€. This deficit will reduce equity on the balance sheet.

EBITDA (2022) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-3 499 €

EBIT (2022) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-3 499 €

Net income (2022) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-14 158 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 100%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.0 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability.

Debt ratio (2022) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.065%

Financial autonomy (2022) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

99.78%

Repayment capacity (2022) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.014

Solvency indicators evolution
SPFPLARL PHARMABABA

Sector positioning

Debt ratio
0.07 2022
2020
2021
2022
Q1: 24.52
Med: 74.72
Q3: 182.51
Excellent -12 pts over 3 years

In 2022, the debt ratio of SPFPLARL PHARMABABA (0.07) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
99.78% 2022
2020
2021
2022
Q1: 28.54%
Med: 47.06%
Q3: 66.61%
Excellent

In 2022, the financial autonomy of SPFPLARL PHARMABABA (99.8%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
0.01 years 2022
2020
2021
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Excellent -29 pts over 3 years

In 2022, the repayment capacity of SPFPLARL PHARMABABA (0.01) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 6259.51. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2022) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

6259.505

Interest coverage (2022) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-172.678

Liquidity indicators evolution
SPFPLARL PHARMABABA

Sector positioning

Liquidity ratio
6259.51 2022
2020
2021
2022
Q1: 145.17
Med: 199.48
Q3: 274.99
Excellent

In 2022, the liquidity ratio of SPFPLARL PHARMABABA (6259.51) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
-172.68x 2022
2020
2021
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Watch

In 2022, the interest coverage of SPFPLARL PHARMABABA (-172.7x) ranks in the bottom 25% of the sector. This ratio indicates how many times operating income covers interest expenses. Low coverage may indicate fragility to rate or income variations.

Positioning of SPFPLARL PHARMABABA in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SPFPLARL PHARMABABA with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SPFPLARL PHARMABABA

What is the revenue of SPFPLARL PHARMABABA ?

The revenue of SPFPLARL PHARMABABA is not publicly disclosed (confidential accounts filed with INPI).

Is SPFPLARL PHARMABABA profitable?

SPFPLARL PHARMABABA recorded a net loss in 2022.

Where is the headquarters of SPFPLARL PHARMABABA ?

The headquarters of SPFPLARL PHARMABABA is located in GENSAC (33890), in the department Gironde.

Where to find the tax return of SPFPLARL PHARMABABA ?

The tax return of SPFPLARL PHARMABABA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SPFPLARL PHARMABABA operate?

SPFPLARL PHARMABABA operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.